Prospect: information for the user
Levofloxacino Aurovitas 500 mg film-coated tablets EFG
Read this prospect carefully before starting to take this medicine, as it contains important information for you.
1.What isLevofloxacino Aurovitas tabletsand for what it is used
2.What you need to know before starting to takeLevofloxacino Aurovitas tablets
3.How to takeLevofloxacino Aurovitas tablets
4.Possible adverse effects
5.Storage ofLevofloxacino Aurovitas tablets
6.Contents of the package and additional information
This medicine is called Levofloxacino Aurovitas tablets coated with EFG film. Levofloxacino Aurovitas contains an active ingredient called levofloxacino, which belongs to a group of medicines called antibiotics. Levofloxacino is an antibiotic of the quinolone type, and it works by eliminating the bacteria that cause infections in your body.
Antibiotics are used to treat bacterial infections and do not work for viral infections such as the flu or a cold.
It is essential that you follow the instructions regarding the dose, administration interval, and treatment duration indicated by your doctor.
Do not store or reuse this medicine. If you have any leftover antibiotic after treatment, return it to the pharmacy for proper disposal. Do not dispose of the medicine by flushing it down the drain or throwing it away.
Levofloxacino Aurovitas can be used to treat infections in:
In certain special situations, levofloxacino may be used to reduce the likelihood of acquiring a type of lung infection called anthrax or a worsening of the disease after exposure to the anthrax-causing bacteria.
Do not take Levofloxacino Aurovitas if
Do not take this medication if any of the above cases apply to you. If in doubt, consult your doctor or pharmacist before taking Levofloxacino Aurovitas tablets.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Levofloxacino Aurovitas if:
Severe skin reactions
Severe skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported with the use of levofloxacino.
If you develop a severe skin reaction or any of these symptoms, stop taking levofloxacino and contact your doctor or seek medical attention immediately.
Quinolone antibiotics, including levofloxacino, can cause an increase in your blood sugar levels above normal levels (hyperglycemia), or a decrease in your blood sugar levels below normal levels, which in severe cases can cause loss of consciousness (see section 4). This is important for people with diabetes. If you have diabetes, your blood sugar levels should be carefully controlled.
Do not take fluoroquinolone or quinolone antibiotics, including levofloxacino, if you have had a severe reaction to a quinolone or fluoroquinolone in the past. If this is the case, inform your doctor as soon as possible.
During treatment with this medication
In rare cases, you may experience pain and swelling in your joints and inflammation or rupture of your tendons.The risk is higher if you are an older person (over 60 years old), have received an organ transplant, have kidney problems, or are taking corticosteroids. Tendon inflammation and rupture can occur within the first 48 hours of treatment and even several months after stopping levofloxacino treatment. If you experience any pain or inflammation in a tendon (e.g., in your ankle, wrist, elbow, shoulder, or knee), stop taking levofloxacino, contact your doctor, and keep the affected area at rest. Avoid any unnecessary exercise, as this may increase the risk of tendon rupture.
In rare cases, you may experience symptoms of nerve damage (neuropathy) such as pain, burning, tingling, numbness, and/or weakness, especially in your feet and legs or hands and arms. If this happens, stop taking levofloxacino and inform your doctor immediately to prevent the development of a potentially irreversible condition.
Severe, prolonged, and potentially irreversible adverse effects
Fluoroquinolone and quinolone antibiotics, including levofloxacino, have been associated with rare but severe adverse effects, some of which were of long duration (persistent for months or years), incapacitating, or potentially irreversible. This includes pain in the tendons, muscles, and joints of the upper and lower extremities, difficulty walking, abnormal sensations such as pinpricks, numbness, tingling, or burning (paresthesia), sensory disorders such as decreased vision, taste, smell, and hearing, depression, decreased memory, intense fatigue, and severe sleep disorders.
If you experience any of these adverse effects after taking levofloxacino, contact your doctor immediately before continuing treatment. You and your doctor will decide whether to continue or not with the treatment, considering also the use of an antibiotic of another class.
Inform your doctor or pharmacist before taking levofloxacino if you are unsure whether any of the above cases applies to you.
Other medications and Levofloxacino Aurovitas
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. This is because levofloxacino may affect the functioning of other medications. Additionally, some medications may affect the functioning of levofloxacino.
Particularly, inform your doctor if you are taking any of the following medications, as it increases the likelihood of experiencing adverse effects when taking them with Levofloxacino Aurovitas:
Do not take Levofloxacino Aurovitas tablets at the same time as the following medications, as it may affect the action of levofloxacino:
Determination of opiates in urine
Urine tests may show “false positive” results for the presence of strong painkillers called “opioids” in patients taking levofloxacino. Inform your doctor that you are taking levofloxacino if they have prescribed a urine test.
Tuberculosis test
This medication may cause a “false negative” result in some laboratory tests used to search for the bacteria that causes tuberculosis.
Pregnancy, breastfeeding, and fertility
If you are pregnant, breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Do not take this medication if:
Driving and operating machinery
You may experience some adverse effects such as dizziness, drowsiness, altered balance (vertigo), or visual disturbances. Some of these adverse effects may affect your ability to concentrate or decrease your reaction time. If this happens, do not drive or perform any work that requires a high level of attention.
Levofloxacino Aurovitas contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially “sodium-free”.
Follow exactly the administration instructions of this medication indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
How to take this medication
If you are already taking iron tablets, zinc supplements, antacids, didanosine or sucralfate
What dose should you take
Adults and elderly patients
Upper respiratory tract infection
Pulmonary infection, in people with long-term respiratory problems
Pneumonia
Urinary tract infection, including kidneys or bladder
Prostate infection
Skin and subcutaneous tissue infection, including muscles
Adults and elderly patients with kidney problems
Your doctor may possibly administer a lower dose.
Use in children and adolescents
This medication should not be administered to children or adolescents.
Protect your skin from the sun
Do not expose your skin directly to the sun (even on cloudy days) while taking this medication and for two days after stopping it, as your skin will become much more sensitive to the sun and may burn, itch or even blister if you do not take the following precautions:
If you take more Levofloxacino Aurovitas tablets than you should
If you accidentally take more tablets than you should, inform your doctor or get immediate medical help. Bring the medication with you so that the doctor knows what you have taken. You can also call the Toxicological Information Service on phone 91 562 04 20, indicating the medication and the amount ingested. The effects that may appear are: epileptic seizures (convulsions), confusion, dizziness, decreased consciousness, tremors, heart rhythm disturbances that may cause irregular heartbeats as well as discomfort (nausea) or heartburn.
If you forget to take Levofloxacino Aurovitas tablets
If you forget to take a dose, take it as soon as you remember, unless it is almost time for your next dose. Do not take a double dose to make up for the missed doses.
If you interrupt treatment withLevofloxacino Aurovitas tablets
Do not interrupt your treatment with levofloxacin even if you feel better. It is essential that you complete the treatment prescribed by your doctor. If you stop taking them too soon, the infection may recur, your condition may worsen, or the bacteria may become resistant to the medication.
If you have any other questions about the product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them. Normally, they are mild to moderate and usually disappear quickly.
Very rare(may affect up to 1 in 10,000 people)
Stop taking Levofloxacino Aurovitas and contact a doctor or go to a hospital quickly if you notice the following side effects:
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(cannot be estimated from available data)
Consult an eye specialist immediately if your vision worsens or you have any other eye problems while taking levofloxacino.
The administration of quinolone and fluoroquinolone antibiotics has been associated with very rare cases of long-lasting or permanent adverse reactions (even months or years after treatment), such as tendon inflammation, tendon rupture, joint pain, limb pain, difficulty walking, abnormal sensations such as pinpricks, numbness, tingling, burning, or pain (neuropathy), depression, fatigue, sleep disorders, memory loss, and hearing, vision, taste, and smell loss, in some cases regardless of pre-existing risk factors.
Cases of increased size and weakening or tearing of the aortic wall (aneurysms and dissections) have been reported, which could lead to rupture and be fatal, and heart valve insufficiency in patients who have received fluoroquinolones. See also section 2.
Inform your doctor if any of the following side effects worsen or last more than a few days:
Frequent(may affect up to 1 in 10 people)
Rare(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Frequency not known(cannot be estimated from available data)
Reporting of adverse reactions:
If you experience any type of adverse reaction, consult your doctor, nurse, or pharmacist, even if it is a possible adverse reaction that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting adverse reactions, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and medicines you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. In this way, you will help protect the environment.
Composition of Levofloxacino Aurovitas tablets
Each film-coated tablet contains 500 mg of levofloxacin (as levofloxacin hemihydrate).
Tablet core:sodium croscarmellose, microcrystalline cellulose, hypromellose, magnesium stearate.
Tablet coating:hypromellose, titanium dioxide (E171), macrogol, talc, yellow iron oxide (E172) and red iron oxide (E172).
Appearance of the product and contents of the packaging
Film-coated tablet.
Levofloxacino Aurovitas 500 mg are pink, biconvex, capsule-shaped film-coated tablets, marked on one face with the numbers “1” and “4” on either side of the break line and with the letter “T” on the other face.
The tablet can be divided into two equal doses.
Levofloxacino Aurovitas is available in blisters of 5, 7, 10 and 14 film-coated tablets.
Only some package sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Aurovitas Spain, S.A.U.
Avda. de Burgos, 16-D
28036 Madrid
Spain
Responsible manufacturer:
APL Swift Services (Malta) Limited
HF26, Hal Far Industrial Estate, Hal Far
Birzebbugia, BBG 3000
Malta
This medicinal product is authorized in the member states of the European Economic Area with the following names:
SpainLevofloxacino Aurovitas 500 mg film-coated tablets EFG
PolandLevofloxacin Aurovitas
PortugalLevofloxacina Aurovitas
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/)
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.